The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.LEUKRES.2006.10.002PMID 17118447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International System for Human Cytogenetic Nomenclature

  2020cited by this paper
• The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia.

  2005cited by this paper
• Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

  2004cited by this paper
• Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.

  2003cited by this paper
• Induction of NAD(P)H quinone oxidoreductase and glutathione S-transferase activities in livers of female August-Copenhagen Irish rats treated chronically with estradiol: comparison with the Sprague-Dawley rat.

  2003cited by this paper
• Inheritance and drug response.

  2003cited by this paper
• Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development.

  2003cited by this paper
• Adjuvant chemotherapy for women with young children: our patients as parents.

  2003cited by this paper
• Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy

  2002cited by this paper
• Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia.

  2002cited by this paper
• Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.

  2001cited by this paper
• Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms.

  2001cited by this paper
• No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.

  2001cited by this paper
• Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia.

  2001cited by this paper
• The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review.

  2000cited by this paper
• Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.

  2000cited by this paper
• Genes and cancer

  1999cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Long‐term survival after chemotherapy for acute myeloid leukemia

  1997cited by this paper
• Long‐term survival of patients with acute myeloid leukemia

  1997cited by this paper
• Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

  1996cited by this paper
• NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.

  1995cited by this paper
• Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo.

  1992cited by this paper
• Glutathione transferases and cancer.

  1992cited by this paper
• NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.

  1992cited by this paper
• Free radical formation by antitumor quinones.

  1989cited by this paper
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• TOXICOKINETICS AND METABOLISM

  year unknowncited by this paper

• Association of genetic predisposition studies in CYP1A1 polymorphism studies in acute myeloid leukemia

  2023cites this paper
• GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation

  2021cites this paper
• Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia

  2021cites this paper
• 10.11 – Quinone Reductases☆

  2018cites this paper
• The polymorphism of JAK2 rs56118985 may be a predictive marker of the treatment responses of acute myeloid leukemia patients

  2017cites this paper
• Pharmacogenomics and the treatment of acute myeloid leukemia.

  2016cites this paper
• Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse

  2016cites this paper
• Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia.

  2016cites this paper
• GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis

  2015cites this paper
• Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcomes in Breast Cancer Patients

  2015cites this paper
• Oxidative Stress-Related Genetic Polymorphisms Are Associated with the Prognosis of Metastatic Gastric Cancer Patients Treated with Epirubicin, Oxaliplatin and 5-Fluorouracil Combination Chemotherapy

  2014cites this paper
• GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis

  2014cites this paper
• XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia

  2014cites this paper
• MDR-1 and GST polymorphisms are involved in myelodysplasia progression.

  2013cites this paper
• Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia.

  2013cites this paper
• Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia

  2013cites this paper
• Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia

  2012influential citation
• CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects

  2012cites this paper
• Polymorphisms in XPC provide prognostic information in acute myeloid leukemia

  2012cites this paper
• Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients

  2012cites this paper
• Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.

  2012cites this paper
• The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.

  2012cites this paper
• Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

  2011cites this paper
• Ⅰ、Ⅱ相药物代谢酶遗传多态性与晚期非小细胞肺癌化疗疗效的关系

  2011cites this paper
• Association of C609T and C465T polymorphisms of NQO1 gene with AML

  2011cites this paper
• Pharmacogenetic and Pharmacogenomic Considerations in the Biology and Treatment of Childhood Leukemia

  2011cites this paper
• POLIMORFISMOS DE ENZIMAS DE FASE 1 E 2 DO METABOLISMO DE DROGAS EM PACIENTES PORTADORES DE LINFOMA DIFUSO DE GRANDES CÉLULAS B

  2011cites this paper
• ارتباط پلیمورفیسمهای C465T و C609T در ژن NQO1 با لوسمی میلوئیدی حاد

  2011cites this paper
• Pharmacogenetics of genes across the doxorubicin pathway

  2011cites this paper
• The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia

  2010cites this paper
• Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma.

  2010cites this paper
• 4.11 – Quinone Reductases

  2010cites this paper
• An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment.

  2009cites this paper
• Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia.

  2009cites this paper
• Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics.

  2009cites this paper
• Inheritance and clinical outcome in childhood acute lymphoblastic leukemia.

  2009cites this paper
• Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes.

  2009cites this paper
• Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia

  2009cites this paper
• Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups.

  2008cites this paper
• Polymorphisms in the glutathione S-transferase theta and mu genes and susceptibility to myeloid leukemia in Brazilian patients

  2008cites this paper
• Pharmacogenetics and Pharmacokinetics in high-dose alkylating chemotherapy

  2008cites this paper
• Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer

  2008cites this paper
• Pharmacogenomics of acute leukemia.

  2007cites this paper
• NQO1*2 polymorphism and response to treatment in patients with multiple myeloma.

  2007cites this paper